| Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs KN Theken, CR Lee, L Gong, KE Caudle, CM Formea, A Gaedigk, ... Clinical Pharmacology & Therapeutics 108 (2), 191-200, 2020 | 255 | 2020 |
| Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation Y Deng, KN Theken, CR Lee Journal of molecular and cellular cardiology 48 (2), 331-341, 2010 | 201 | 2010 |
| PharmGKB summary: ibuprofen pathways LL Mazaleuskaya, KN Theken, L Gong, CF Thorn, GA FitzGerald, ... Pharmacogenetics and genomics 25 (2), 96-106, 2015 | 185 | 2015 |
| Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice Y Deng, ML Edin, KN Theken, RN Schuck, GP Flake, MA Kannon, ... The FASEB Journal 25 (2), 703, 2011 | 145 | 2011 |
| Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism KN Theken, Y Deng, MA Kannon, TM Miller, SM Poloyac, CR Lee Drug metabolism and disposition 39 (1), 22-29, 2011 | 142 | 2011 |
| Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease KN Theken, RN Schuck, ML Edin, B Tran, K Ellis, A Bass, FB Lih, ... Atherosclerosis 222 (2), 530-536, 2012 | 124 | 2012 |
| Cyclooxygenase inhibition: pain, inflammation, and the cardiovascular system T Grosser, KN Theken, GA FitzGerald Clinical Pharmacology & Therapeutics 102 (4), 611-622, 2017 | 84 | 2017 |
| Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients RN Schuck, KN Theken, ML Edin, M Caughey, A Bass, K Ellis, B Tran, ... Atherosclerosis 227 (2), 442-448, 2013 | 73 | 2013 |
| Nonsteroidal anti-inflammatory drugs and opioids in postsurgical dental pain EV Hersh, PA Moore, T Grosser, RC Polomano, JT Farrar, M Saraghi, ... Journal of dental research 99 (7), 777-786, 2020 | 71 | 2020 |
| The roles of lipids in SARS-CoV-2 viral replication and the host immune response KN Theken, SY Tang, S Sengupta, GA FitzGerald Journal of lipid research 62, 2021 | 59 | 2021 |
| Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk KN Theken, CR Lee Future Medicine Ltd 8 (10), 1369-1383, 2007 | 55 | 2007 |
| Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism KN Theken, Y Deng, RN Schuck, A Oni-Orisan, TM Miller, ... American Journal of Physiology-Endocrinology and Metabolism 302 (5), E500-E509, 2012 | 54 | 2012 |
| Cold-induced browning of inguinal white adipose tissue is independent of adipose tissue cyclooxygenase-2 GK Paschos, SY Tang, KN Theken, X Li, I Verginadis, D Lekkas, ... Cell reports 24 (4), 809-814, 2018 | 41 | 2018 |
| Variability in analgesic response to non-steroidal anti-inflammatory drugs KN Theken Prostaglandins & other lipid mediators 139, 63-70, 2018 | 40 | 2018 |
| Bioactive lipids in antiviral immunity KN Theken, GA FitzGerald Science 371 (6526), 237-238, 2021 | 28 | 2021 |
| Variability in the analgesic response to ibuprofen is associated with cyclooxygenase activation in inflammatory pain KN Theken, EV Hersh, NF Lahens, HM Lee, X Li, EJ Granquist, ... Clinical pharmacology & therapeutics 106 (3), 632-641, 2019 | 27 | 2019 |
| Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice A Oni-Orisan, Y Deng, RN Schuck, KN Theken, ML Edin, FB Lih, K Molnar, ... Prostaglandins & other lipid mediators 104, 67-73, 2013 | 27 | 2013 |
| Loss of circadian protection against influenza infection in adult mice exposed to hyperoxia as neonates Y Issah, A Naik, SY Tang, K Forrest, TG Brooks, N Lahens, KN Theken, ... Elife 10, e61241, 2021 | 17 | 2021 |
| Weight-adjusted aspirin for cardiovascular prevention KN Theken, T Grosser The Lancet 392 (10145), 361-362, 2018 | 12 | 2018 |
| A pair of “ACEs” EV Hersh, M Wolff, PA Moore, KN Theken, H Daniell Journal of dental research 101 (1), 5-10, 2022 | 11 | 2022 |
